These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 8370322

  • 1. Antimicrobial activity of new antibiotics against bacterial isolates from a community hospital.
    Dyke JW, Angones D, Bhakta D, Tenjarla G, Kumar A.
    Chemotherapy; 1993; 39(5):315-21. PubMed ID: 8370322
    [Abstract] [Full Text] [Related]

  • 2. Antibacterial properties of investigational, new, and commonly used antibiotics against isolates of Pseudomonas cepacia in Michigan.
    Bhakta DR, Leader I, Jacobson R, Robinson-Dunn B, Honicky RE, Kumar A.
    Chemotherapy; 1992; 38(5):319-23. PubMed ID: 1283733
    [Abstract] [Full Text] [Related]

  • 3. In-vitro antimicrobial activity of Cefpirome: a new fourth-generation cephalosporin against clinically significant bacteria.
    Hafeez S, Izhar M, Ahmed A, Zafar A, Naeem M.
    J Pak Med Assoc; 2000 Aug; 50(8):250-2. PubMed ID: 10992706
    [Abstract] [Full Text] [Related]

  • 4. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL, Smith RP, Ritz W.
    Chemotherapy; 1994 Aug; 40(6):391-8. PubMed ID: 7842822
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of cefepime and cefpirome compared to other third-generation cephem antibiotics against gram-negative nosocomial pathogens.
    Tumah HN.
    Pharmazie; 2004 Nov; 59(11):854-8. PubMed ID: 15587586
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the in vitro Activity of Two Fourth-Generation Cephalosporins Against Bacterial Samples Isolated From Patients in Several Brazilian Hospitals.
    Cereda RF, Sader HS, Barth AL, Segura A, Kage R, Novakonski A, Pignatari AC.
    Braz J Infect Dis; 1999 Oct; 3(5):189-196. PubMed ID: 11084667
    [Abstract] [Full Text] [Related]

  • 7. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
    [Abstract] [Full Text] [Related]

  • 8. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
    Arsalan A, Naqvi SB, Ali SA, Ahmed S, Shakeel O.
    Pak J Pharm Sci; 2015 May; 28(3):841-7. PubMed ID: 26004702
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of cefdinir (FK482) and ten other antibiotics against gram-positive and gram-negative bacteria isolated from adult and pediatric patients.
    Sultan T, Baltch AL, Smith RP, Ritz W.
    Chemotherapy; 1994 May; 40(2):80-91. PubMed ID: 8131638
    [Abstract] [Full Text] [Related]

  • 10. Activity of cefepime compared with other antibiotics against gram-positive bacteria and cefuroxime-resistant gram-negative bacteria.
    Wang FD, Liu IM, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):408-13. PubMed ID: 9699393
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R, Mittermayer H, Feierl G, Allerberger F, Wendelin I, Hirschl A, Reisinger EC.
    Wien Klin Wochenschr; 1999 Jul 30; 111(14):549-54. PubMed ID: 10467641
    [Abstract] [Full Text] [Related]

  • 12. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan 30; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 13. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
    Tuchiluş C, Poiată A, Bădicuţ I, Teodor A, Luca V, Grigore L, Buiuc D.
    Rev Med Chir Soc Med Nat Iasi; 2003 Jan 30; 107(3):595-8. PubMed ID: 14756068
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
    Mitsukude M, Inoue M, Mitsuhashi S.
    Arzneimittelforschung; 1989 Jan 30; 39(1):26-30. PubMed ID: 2785801
    [Abstract] [Full Text] [Related]

  • 15. Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin.
    Tumah H.
    Chemotherapy; 2005 May 30; 51(2-3):80-5. PubMed ID: 15870501
    [Abstract] [Full Text] [Related]

  • 16. Antibacterial activity of cefprozil in vitro.
    Liu YC, Huang WK, Chen DL.
    Chemotherapy; 1995 May 30; 41(6):427-32. PubMed ID: 8529432
    [Abstract] [Full Text] [Related]

  • 17. Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
    Bakhtiar M, Selwyn S.
    Drugs Exp Clin Res; 1989 May 30; 15(10):477-82. PubMed ID: 2698794
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility of Klebsiella spp. to cefpirome and cefepime.
    Tuchiluş C, Poiată A, Iancu LS, Bădicuţ I, Ambăruş A, Buiuc D.
    Rev Med Chir Soc Med Nat Iasi; 2006 May 30; 110(2):465-7. PubMed ID: 17802963
    [Abstract] [Full Text] [Related]

  • 19. Comparative study on resistant pattern of clinical isolates against levofloxacin and cefepime.
    Nasiri MI, Naqvi SB, Zaidi AA, Saeed R, Raza G.
    Pak J Pharm Sci; 2013 Mar 30; 26(2):415-9. PubMed ID: 23455216
    [Abstract] [Full Text] [Related]

  • 20. Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
    Schatz BS, Karavokiros KT, Taeubel MA, Itokazu GS.
    Ann Pharmacother; 1996 Mar 30; 30(3):258-68. PubMed ID: 8833562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.